Zevra Therapeutics
ZVRA
#7128
Rank
S$0.51 B
Marketcap
$9.47
Share price
-5.25%
Change (1 day)
45.64%
Change (1 year)

Operating Margin for Zevra Therapeutics (ZVRA)

Operating Margin as of April 2025 (TTM): -350.62%

According to Zevra Therapeutics's latest financial reports and stock price the company's current Operating Margin is -350.62%. At the end of 2024 the company had an Operating Margin of -381.76%.

Operating Margin history for Zevra Therapeutics from 2020 to 2024

Operating Margin at the end of each year

Year Operating Margin Change
2024-381.76%
2022-263.80%786.98%
2021-29.74%-69.11%
2020-96.28%-49.63%
2019-191.17%

What is a company's Operating Margin?

The operating margin is a key indicator to assess the profitability of a company. Higher operating margins are generaly better as they show that a company is able to sell its products or services for much more than their production costs. The operating margin is calculated by dividing a company's earnings by its revenue.